ArticleRadiology2017
Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.
Abstract read
In one paragraph
Article in Radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 25 citations in OpenAlex.
- Gold nanocomposites in colorectal cancer therapy: characterization, selective cytotoxicity, and migration inhibition.Naunyn-Schmiedeberg's archives of pharmacology · 2025Article
- Metal ions and nanomaterials for targeted bone cancer immunotherapy.Frontiers in immunology · 2025Review
- New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy.Cancers · 2023Review
- Multifunctional Iron Oxide Magnetic Nanoparticles for Biomedical Applications: A Review.Materials (Basel, Switzerland) · 2022Review
- Recent Advances in Transition-Metal Based Nanomaterials for Noninvasive Oncology Thermal Ablation and Imaging Diagnosis.Frontiers in chemistry · 2022Review
- Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies.Nanomaterials (Basel, Switzerland) · 2021Review
- Multifunctional Nanocarriers-Mediated Synergistic Combination of Immune Checkpoint Inhibitor Cancer Immunotherapy and Interventional Oncology Therapy.Advanced nanobiomed research · 2021Article
- Transarterial Embolization of Liver Cancer in a Transgenic Pig Model.Journal of vascular and interventional radiology : JVIR · 2021Article
- Gold Nanoparticles Functionalized with Angiogenin for Wound Care Application.Nanomaterials (Basel, Switzerland) · 2021Article
- Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer.Cancer biology & medicine · 2020Review
- Localized and triggered release of oxaliplatin for the treatment of colorectal liver metastasis.Journal of Cancer · 2020Article
- Photothermal therapy technology of metastatic colorectal cancer.American journal of translational research · 2020Review
- Near-Infrared Fluorescent Endoscopic Image-Guided Photothermal Ablation Therapy of Colorectal Cancer Using Dual-Modal Gold Nanorods Targeting Tumor-Infiltrating Innate Immune Cells in a Transgenic TS4 CRE/APCACS applied materials & interfaces · 2019Article
- Nanovectors Design for Theranostic Applications in Colorectal Cancer.Journal of oncology · 2019Review
- Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods.ACS nano · 2018Article
- Image-Guided Cancer Nanomedicine.Journal of imaging · 2018Article
- Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles.Radiology · 2017Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 2 institutions in 1 country.
Sarah B WhiteFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Dong-Hyun KimFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Yang GuoFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Weiguo LiFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Yihe YangFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Jeane ChenFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Venkateswara R GogineniFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Andrew C LarsonFrom the Department of Radiology, Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wis (S.B.W., V.R.G.); Department of Radiology (S.B.W., D.H.K., Y.G., W.L., Y.Y., J.C., A.C.L.) and Robert H. Lurie Comprehensive Cancer Center (D.H.K., A.C.L.), Northwestern University, 710 N Fairbanks Ct, Olson 8th floor 8-317, Chicago, IL 60611; Department of Chemical and Biological Engineering (J.C.) and Department of Biomedical Engineering (A.C.L.), Northwestern University, Evanston, Ill.
Northwestern University · USMedical College of Wisconsin · US
Funding
Cancer Nanotechnology in Imaging and RadiotherapyR25CA132822 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLOSCHAK, GAYLE E. · 2009 to 2013
$2.0MNCI NIH HHS R25 CA132822
Abstract
Purpose To demonstrate that anti-MG1 conjugated hybrid magnetic gold nanoparticles (HNPs) act as a catalyst during photothermal ablation (PTA) of colorectal liver metastases, and thus increase ablation zones. Materials and Methods All experiments were performed with approval of the institutional animal care and use committee. Therapeutic and diagnostic multifunctional HNPs conjugated with anti-MG1 monoclonal antibodies were synthesized, and the coupling efficiency was determined. Livers of 19 Wistar rats were implanted with 5 × 10
Indexed as
AnimalsAntibodies, MonoclonalCell Line, TumorColorectal NeoplasmsGoldHyperthermia, InducedLiver NeoplasmsLow-Level Light TherapyMagnetite NanoparticlesMucin-5BNanoconjugatesRatsRats, WistarTreatment OutcomeAntibodies, MonoclonalGoldMagnetite NanoparticlesMUC5B protein, humanMucin-5BNanoconjugates
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.